GHK-Cu for Liver: What the Evidence Shows
What human and animal studies show about GHK-Cu for liver, how strong that evidence is, and what is still unproven.
- Strongest evidence
- None graded
- no study with an outcome for liver (PubMed search, 11 Oct 2026)
- Human studies
- None found
- with an outcome for liver, in our evidence file (PubMed search, 11 Oct 2026)
- Animal studies
- None found
- with an outcome for liver, in our evidence file (PubMed search, 11 Oct 2026)
Evidence for liver
None of the study abstracts we summarised for GHK-Cu reported an outcome for liver (PubMed search, 11 Oct 2026). Claims that it helps with liver are unproven.
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
MedlinePlus background on the liver
MedlinePlus introduces the liver as the largest organ inside the body, which is the baseline for reading the GHK-Cu studies below.[10]
What the GHK-Cu research on the liver actually reports
A PubMed title-and-abstract search pairing GHK-Cu terms with the liver terms, run on 29 Oct 2026, matched 17 records; the count measures how much has been written, not what it found.
Calculated from pubmed query ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (liver[tiab] OR hepat*[tiab] OR steato*[tiab] OR NAFLD[tiab] OR NASH[tiab] OR MASLD[tiab] OR MASH[tiab] OR cirrho*[tiab]); date 2026-10-29; record count 17. Formula: number of PubMed records matching the query on the date shown, as recorded by the ledger run in research/keywords/expansion-2026-10/build/ledger-results.json
In rat liver cells grown in a dish, the tripeptide Gly-His-Lys, which is GHK without copper, moderately raised several plasma proteins at low concentration; it is a cell-culture result.[11]
In an animal study, repeated injections of Gly-His-Lys stimulated liver-cell division and suppressed immune reactivity in a dose-dependent way.[12]
Limits to keep in mind for GHK-Cu and the liver
A review of GHK-Cu lists the liver among tissues where tissue repair has been demonstrated for GHK, without naming the studies in its abstract.[13]
Other peptides people research for liver
All peptides for liver, comparedCommon questions
Does GHK-Cu help with liver?
None of the studies we summarised for GHK-Cu (PubMed search, 11 Oct 2026) measured an outcome for liver. Treat claims that it helps with liver as unproven.
Is GHK-Cu approved for liver?
No. GHK-Cu is not FDA approved for any use, including liver.
What is the best peptide for liver?
There is no single answer. Our liver overview compares each candidate by evidence grade and legal status rather than by popularity.
How does MedlinePlus describe the liver?
The National Library of Medicine's MedlinePlus gives this plain-language description of the liver, the condition behind the GHK-Cu question.[10]
Is there published research on GHK-Cu and the liver?
A PubMed search on 29 Oct 2026 pairing GHK-Cu terms with the liver terms matched 17 records, which says research exists in the literature and not that GHK-Cu has any effect on the liver.
Calculated from pubmed query ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (liver[tiab] OR hepat*[tiab] OR steato*[tiab] OR NAFLD[tiab] OR NASH[tiab] OR MASLD[tiab] OR MASH[tiab] OR cirrho*[tiab]); date 2026-10-29; record count 17. Formula: number of PubMed records matching the query on the date shown, as recorded by the ledger run in research/keywords/expansion-2026-10/build/ledger-results.json
More on GHK-Cu
Sources
- 1PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) (431 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 2PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (humans[mh] OR patients[tiab] OR volunteers[tiab]) (150 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (randomized[tiab] OR clinical trial[pt] OR split-face[tiab]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (wound[tiab] OR hair[tiab] OR skin[tiab] OR wrinkle*[tiab]) (123 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: ("GHK-Cu"[tiab] OR GHK[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (rat[tiab] OR mice[tiab] OR rats[tiab] OR animal[tiab]) (80 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (facial[tiab] OR cream[tiab] OR photodamage[tiab] OR volunteers[tiab] OR women[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (hair[tiab] OR alopecia[tiab]) (16 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9PubMed search: ("GHK-Cu"[tiab] OR "copper tripeptide"[tiab] OR "copper peptide"[tiab] OR "copper peptides"[tiab] OR "glycyl-L-histidyl-L-lysine"[tiab] OR "glycyl-histidyl-lysine"[tiab] OR "Gly-His-Lys"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (38 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 10Official web pageOfficial web page · web page
- 11Effect of glucocorticoids, insulin and a growth promoting tripeptide on the biosynthesis of plasma proteins in serum-free hepatocyte cultures.Zeitschrift fur Naturforschung. Section C, Biosciences · 1981PMID 7018103Accessed 29 Oct 2026
- 12Tripeptide Gly-His-Lys is a hepatotropic immunosuppressor.Bulletin of experimental biology and medicine · 2002PMID 12447473Accessed 29 Oct 2026
- 13Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.International journal of molecular sciences · 2018PMID 29986520Accessed 2 Oct 2026
Found an error? Report a correction.